Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Comparative Effectiveness Funded By Public-Private Trust Proposed In House

Executive Summary

Efforts to enhance the role and resources for research comparing the effectiveness of drugs and medical devices gained another boost May 7, with legislation introduced by Reps. Tom Allen, D-Maine, and Jo Ann Emerson, R-Mo

You may also be interested in...



Large Payers, Including CMS, PBMs, Mostly Absent From PCORI Board

With some very overt participation in comparative effectiveness research, one may have expected representatives from traditional large health care organizations or pharmacy benefit managers to be appointed to the Patient-Centered Outcomes Research Institute first board of governors. However, they were left off the board, announced Sept. 23.

Large Payers, Including CMS, PBMs, Mostly Absent From PCORI Board

With some very overt participation in comparative effectiveness research, one may have expected representatives from traditional large health care organizations or pharmacy benefit managers to be appointed to the Patient-Centered Outcomes Research Institute first board of governors. However, they were left off the board, announced Sept. 23.

Health Plans Readying For Comparative Effectiveness Push Next Year

With drug spending on the rise, health plans expect new federal policy on comparative effectiveness is imminent.

Related Content

UsernamePublicRestriction

Register

PS048348

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel